1. Home
  2. PAR vs SUPN Comparison

PAR vs SUPN Comparison

Compare PAR & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAR
  • SUPN
  • Stock Information
  • Founded
  • PAR 1968
  • SUPN 2005
  • Country
  • PAR United States
  • SUPN United States
  • Employees
  • PAR N/A
  • SUPN N/A
  • Industry
  • PAR Office Equipment/Supplies/Services
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAR Miscellaneous
  • SUPN Health Care
  • Exchange
  • PAR Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • PAR 2.4B
  • SUPN 2.6B
  • IPO Year
  • PAR N/A
  • SUPN 2012
  • Fundamental
  • Price
  • PAR $37.88
  • SUPN $47.92
  • Analyst Decision
  • PAR Strong Buy
  • SUPN Buy
  • Analyst Count
  • PAR 7
  • SUPN 2
  • Target Price
  • PAR $78.43
  • SUPN $51.50
  • AVG Volume (30 Days)
  • PAR 961.3K
  • SUPN 682.2K
  • Earning Date
  • PAR 11-07-2025
  • SUPN 11-03-2025
  • Dividend Yield
  • PAR N/A
  • SUPN N/A
  • EPS Growth
  • PAR N/A
  • SUPN 1411.53
  • EPS
  • PAR N/A
  • SUPN 1.14
  • Revenue
  • PAR $418,022,000.00
  • SUPN $665,125,000.00
  • Revenue This Year
  • PAR $29.03
  • SUPN $6.71
  • Revenue Next Year
  • PAR $15.00
  • SUPN $19.74
  • P/E Ratio
  • PAR N/A
  • SUPN $42.23
  • Revenue Growth
  • PAR 45.74
  • SUPN 5.55
  • 52 Week Low
  • PAR $37.29
  • SUPN $29.16
  • 52 Week High
  • PAR $82.24
  • SUPN $49.66
  • Technical
  • Relative Strength Index (RSI)
  • PAR 22.74
  • SUPN 66.02
  • Support Level
  • PAR $37.42
  • SUPN $47.34
  • Resistance Level
  • PAR $39.25
  • SUPN $49.66
  • Average True Range (ATR)
  • PAR 1.34
  • SUPN 1.23
  • MACD
  • PAR 0.13
  • SUPN -0.08
  • Stochastic Oscillator
  • PAR 8.14
  • SUPN 66.70

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: